Latest France News

Orora’s FY26 results reveal a $616.6 million statutory loss driven by a $742.8 million Glass impairment, offset by robust growth in its Cans business and disciplined capital management.

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.

Black Horse Mining Limited completed an $8 million IPO and acquired an 80% stake in the Mt Egerton Gold Project holder. The company reported a $5.87 million loss for FY26, driven by exploration costs and significant share-based payments.

Gentrack Group is set to refresh its board with three new independent directors, while two long-serving members prepare to retire by year-end, marking a strategic governance renewal.

Viridis Mining's Demonstration Plant for Mixed Rare Earth Carbonate production has outperformed Pre-Feasibility Study assumptions, achieving average magnetic rare earth oxide recoveries near 79% during steady operation in July 2026.

Mayfield Childcare has launched a $3 million entitlement offer, fully covered by major shareholder pre-commitments and partial underwriting, to bolster working capital and support its operational turnaround amid ongoing sector challenges.

Eden Innovations reported strong EdenCrete® trial results in India and North America, strategic hires for EdenShield® in defence markets, and completed a $4.05 million placement, ending the quarter debt-free with $5.2 million cash.

Vitrafy Life Sciences reported a breakthrough 94.4% post-thaw platelet recovery in US Army Phase II testing, secured major US blood network partnerships, and raised $32 million to accelerate US expansion and device manufacturing.

Way2VAT Ltd lifted its Q2 FY26 revenue by 30%, launching the Way2Invoice e-invoicing platform amid growing global VAT compliance demands. The company also expanded its debt facility to support growth and pursue M&A opportunities.

Prescient Therapeutics boosted enrolment in its PTX-100 Phase 2a trial to 28 patients and appointed Dr Rosalind Wilson as Chief Medical Officer, strengthening its clinical leadership as it advances targeted cancer therapies.

Vulcan Energy has kicked off civil construction at its Lionheart geothermal power plant in Landau, marking a key milestone in its integrated lithium and renewable energy project targeting 24,000 tonnes of lithium hydroxide annually.

Viridis Mining's Colossus Demonstration Plant has exceeded metallurgical recovery rates assumed in its Pre-Feasibility Study, operating continuously with promising implications for project economics and financing.